Craig; Andrew Simon

Patent Applications and Registrations

Patent applications and USPTO patent grants for Craig; Andrew Simon.The latest application filed is for "anhydrate forms of a pyridine derivative".

Company Profile

0.6.33

Craig; Andrew Simon - Stevenage N/A GB
Craig; Andrew Simon - Kent GB
Craig; Andrew Simon - Tonbridge GB
CRAIG; Andrew Simon - Harlow GB
Craig, Andrew Simon - Sevenoaks GB
Craig, Andrew Simon - Tonbridge Kent GB

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Crystalline 2-(3,5-Bis(trifluoromethyl)phenyl)-N-(4-(4-fluoro-2-methylphenyl)-6-((7S,- 9aS)-7-(hydroxymethyl)hexahydropyrazino[2,1-c][1,4]oxazin-8(1H)-yl)pyridin- -3-yl)-N,2-dimethyl-propanamide of the formula (I), their use in therapy, and process for the preparation of the same Grant 8,796,269 - Craig , et al. August 5, 2	2014-08-05
Anhydrate Forms Of A Pyridine Derivative App 20120157450 - Craig; Andrew Simon ; et al.	2012-06-21
Quinazoline Salt Compounds App 20110245496 - Craig; Andrew Simon ; et al.	2011-10-06
5-[4-[2-(N-methyl-N-(2-pyridyl)amino)ethoxy]benzyl]thiazolidine-2,4-dione Mesylate salt Grant 7,291,740 - Craig , et al. November 6, 2	2007-11-06
Hydrochloride Salt Of 5-[4-[2-(n-methyl-n-(2-pyridyl)amino)ethoxy]benzyl]thiazolidine-2,4-dione App 20070191435 - Craig; Andrew Simon ; et al.	2007-08-16
Sodium Salts Of 5-[4-[2-(n-methyl-n-(2-pyridyl)amino)ethoxy]benzyl]thiazolidine-2,4-dione App 20070185167 - CRAIG; Andrew Simon ; et al.	2007-08-09
Process for preparing a polymorph or rosiglitazone maleate App 20070167494 - Craig; Andrew Simon ; et al.	2007-07-19
Hydrochloride salts of 5-[4-[2-(n-methyl-n-(2-pyridyl) amino)ethoxy]benzyl]thiazolidine-2,4-dione Grant 7,074,811 - Craig July 11, 2	2006-07-11
Inclusion complexes of rosiglitazone App 20060094691 - Craig; Andrew Simon ; et al.	2006-05-04
5-[4-[2-(N-methyl-N-(2-pyridyl)amino)ethoxy]benzyl]thiazolidine-2,4-dione Mesylate salt App 20060040993 - Craig; Andrew Simon ; et al.	2006-02-23
Sodium salts of 5-'4-'2-(N-methyl-N-(2-pyridyl) amino) ethoxy!benzyl!thiazolidine -2, 4-dione App 20060004058 - Craig; Andrew Simon ; et al.	2006-01-05
Hydrochloride salt of 5-[4-[2-(N-methyl-N-(2-pyridyl)amino)ethoxy]benzyl]t- hiazo-lidine-2,4-dione App 20050282867 - Craig, Andrew Simon ; et al.	2005-12-22
Sodium salts of 5-'4-'2-(N-methyl-N-(2-pyridyl)amino)ethoxy!benzyl!thiazol- idine-2, 4-dione App 20050277679 - Craig, Andrew Simon ; et al.	2005-12-15
Hydrochloride salts of 5-[4-[2-(N-methyl-N-(2-pyridyl)amino)ethoxy]benzyl]- thiazolidine-2,4-dione App 20050267162 - Craig, Andrew Simon	2005-12-01
Novel compound App 20040247667 - Al-Ghazawi, Ahmad Khalaf Al-Deeb ; et al.	2004-12-09
Sodium salts of 5-'4-'2-(N-methyl-N-(2-pyridyl)amino)ethoxy!benzyl!thiazol- idine-2, 4-dione App 20040214866 - Craig, Andrew Simon ; et al.	2004-10-28
Hydrochloride salts of 5-[4-[2-(n-methyl-n-(2-pyridyl) amino)ethoxy]benzyl]thiazolidine-2,4-dione App 20040152901 - Craig, Andrew Simon	2004-08-05
Tartrate salt of thiazolidinedione derivative App 20040102485 - Craig, Andrew Simon ; et al.	2004-05-27
Tartrate salts of thiazolidinedione derivative App 20040087629 - Choudary, Berndette Marie ; et al.	2004-05-06
5'-4-'2-(n-methyl-n-(2-pyridyl)amino)ethoxy!benzyl!thiazolidine-2, 4-dione mesylate salt App 20040082620 - Craig, Andrew Simon ; et al.	2004-04-29
Tartrate salts of thiazollidnedione derivative App 20040048899 - Choudary, Bernadette Marie ; et al.	2004-03-11
Thiazolidinedione derivative and its use as antidiabetic App 20040044043 - Craig, Andrew Simon ; et al.	2004-03-04
Paroxetine compositions Grant 6,699,882 - Craig , et al. March 2, 2	2004-03-02
Hydrochloride salt of 5-[4-[2-(n-methyl-n-(2-pyridyl)amino)ethoxy]thiazoli- dine-2,4-dione App 20040034066 - Craig, Andrew Simon ; et al.	2004-02-19
Thiazolidinone nitrate salt App 20040029926 - Craig, Andrew Simon ; et al.	2004-02-12
5(4-(2-(n-methyl-n-(2-pyridyl)amino)ethoxy)benzyl)thiazolidine-2,4-dione hydriodide as pharmaceutical App 20040024027 - Craig, Andrew Simon ; et al.	2004-02-05
Thiazolidinedione derivative and its use as antidiabetic App 20040014791 - Craig, Andrew Simon ; et al.	2004-01-22
Sodium salts of 5-[4-]2-(n-methyl-N-(2-pyridyl) ethoxy]benzyl]thiazolidine- -2,4-dione App 20040014752 - Craig, Andrew Simon ; et al.	2004-01-22
Tartrate salt of thiazolidinedione derivative App 20040014790 - Craig, Andrew Simon ; et al.	2004-01-22
Novel compound App 20030203937 - Al-Ghazawi, Ahmad Khalaf Al-Deeb ; et al.	2003-10-30
Thiazolidinedione salt for treatment of diabetes mellitus App 20030162815 - Craig, Andrew Simon ; et al.	2003-08-28
Novel compound App 20020193406 - Craig, Andrew Simon ; et al.	2002-12-19
Paroxetine compositions App 20020123511 - Craig, Andrew Simon ; et al.	2002-09-05
Novel compound App 20020035130 - Craig, Andrew Simon ; et al.	2002-03-21
Novel compound App 20010023253 - Craig, Andrew Simon ; et al.	2001-09-20
Novel compound App 20010023252 - Al-Ghazawi, Ahmad Khalaf Al-Deeb ; et al.	2001-09-20
Novel process App 20010008940 - Craig, Andrew Simon ; et al.	2001-07-19
Paroxetine derivatives Grant 6,063,927 - Craig , et al. May 16, 2	2000-05-16

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.